Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM3LD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,073
Award facts
- Contract value 100% obligated
- $22,073.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 29, 2026, by the Defense Logistics Agency (DLA) for the supply of OPDIVO 240 mg/24 mL vials. The contract carries a ceiling value of $22,073.28 with a firm fixed-price structure and is scheduled for ultimate completion by February 20, 2026. This delivery order was competitively awarded with no set-aside designation and represents a single task order under the company's broader pharmaceutical supply relationship with DLA.
This award is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent IDC with DLA and serves critical roles in supplying pharmaceutical products, vaccines, and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The delivery of OPDIVO, a oncology pharmaceutical, exemplifies the company's role in providing specialized medications across multiple therapeutic domains to federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FM3LD?
SPE2DR26FM3LD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM3LD worth?
The government has obligated $22,073 on SPE2DR26FM3LD.
Is contract SPE2DR26FM3LD an order under another contract?
Yes. SPE2DR26FM3LD is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3LD competed?
The extent of competition for SPE2DR26FM3LD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award